{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:28:52Z","timestamp":1793305732273,"version":"4.5.0"},"reference-count":289,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["EP\/S023054\/1"],"award-info":[{"award-number":["EP\/S023054\/1"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.bmc.2023.117368","type":"journal-article","created":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T11:37:48Z","timestamp":1686397068000},"page":"117368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Growth factors and their peptide mimetics for treatment of traumatic brain injury"],"prefix":"10.1016","volume":"90","author":[{"given":"Emily","family":"Atkinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3139-5423","authenticated-orcid":false,"given":"Rachael","family":"Dickman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2023.117368_b0005","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.3171\/2017.10.JNS17352","article-title":"Estimating the global incidence of traumatic brain injury","volume":"130","author":"Dewan","year":"2019","journal-title":"J Neurosurg JNS"},{"key":"10.1016\/j.bmc.2023.117368_b0010","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/HTR.0b013e3181c15600","article-title":"Long-term neurologic outcomes after traumatic brain injury","volume":"24","author":"Bazarian","year":"2009","journal-title":"J Head Trauma Rehabil"},{"key":"10.1016\/j.bmc.2023.117368_b0015","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0140-6736(74)91639-0","article-title":"Assessment of coma and impaired consciousness. A practical scale","volume":"2","author":"Teasdale","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.bmc.2023.117368_b0020","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/S0140-6736(05)67626-X","article-title":"Trends in head injury outcome from 1989 to 2003 and the effect of neurosurgical care: an observational study","volume":"366","author":"Patel","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.bmc.2023.117368_b0025","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0140-6736(00)02689-1","article-title":"Traumatic brain injury","volume":"356","author":"Ghajar","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.bmc.2023.117368_b0030","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3390\/biomedicines8100389","article-title":"Revisiting traumatic brain injury: from molecular mechanisms to therapeutic interventions","volume":"8","author":"Jarrahi","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.bmc.2023.117368_b0035","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.mcna.2019.11.001","article-title":"Traumatic brain injury: an overview of epidemiology, pathophysiology, and medical management","volume":"104","author":"Capizzi","year":"2020","journal-title":"Med Clin N Am"},{"key":"10.1016\/j.bmc.2023.117368_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112079","article-title":"Drosophila as a model to explore secondary injury cascades after traumatic brain injury","volume":"142","author":"Buhlman","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.bmc.2023.117368_b0045","doi-asserted-by":"crossref","unstructured":"Long-Term Consequences of Traumatic Brain Injury: Current Status of Potential Mechanisms of Injury and Neurological Outcomes. J Neurotrauma 32; 2015:1834\u201348. 10.1089\/neu.2014.3352.","DOI":"10.1089\/neu.2014.3352"},{"key":"10.1016\/j.bmc.2023.117368_b0050","unstructured":"NICE. Head Injury: assessment and early management [CG176]; 2019. https:\/\/www.nice.org.uk\/guidance\/cg176\/chapter\/Recommendations [accessed 05 April 2023]."},{"key":"10.1016\/j.bmc.2023.117368_b0055","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1007\/s00415-019-09541-4","article-title":"Recent advances in traumatic brain injury","volume":"266","author":"Khellaf","year":"2019","journal-title":"J Neurol"},{"key":"10.1016\/j.bmc.2023.117368_b0060","unstructured":"NIH National Institute of Neurologigal Disorders and Stroke. Traumatic Brain Injury (TBI); 2023. https:\/\/www.ninds.nih.gov\/health-information\/disorders\/traumatic-brain-injury-tbi [accessed 05 April 2023]."},{"key":"10.1016\/j.bmc.2023.117368_b0065","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1186\/s13287-022-03054-0","article-title":"Clinical application of mesenchymal stem cell in regenerative medicine: a narrative review","volume":"13","author":"Margiana","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.bmc.2023.117368_b0070","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3389\/fbioe.2019.00469","article-title":"Growth factor engineering strategies for regenerative medicine applications","volume":"7","author":"Ren","year":"2020","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.bmc.2023.117368_b0075","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41536-017-0028-x","article-title":"Translational considerations in injectable cell-based therapeutics for neurological applications: concepts, progress and challenges","volume":"2","author":"Amer","year":"2017","journal-title":"npj Regen Med"},{"key":"10.1016\/j.bmc.2023.117368_b0080","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nrd.2018.110","article-title":"Gene therapy for neurological disorders: progress and prospects","volume":"17","author":"Deverman","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmc.2023.117368_b0085","doi-asserted-by":"crossref","DOI":"10.1177\/2041731412442668","article-title":"Safety of recombinant human platelet-derived growth factor-BB in Augment\u00ae Bone Graft","volume":"3","author":"Solchaga","year":"2012","journal-title":"J Tissue Eng"},{"key":"10.1016\/j.bmc.2023.117368_b0090","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.diabres.2007.06.004","article-title":"Recombinant human epidermal growth factor (REGEN-D\u2122 150): effect on healing of diabetic foot ulcers","volume":"78","author":"Mohan","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.bmc.2023.117368_b0095","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.pharmthera.2013.01.004","article-title":"GDNF, NGF and BDNF as therapeutic options for neurodegeneration","volume":"138","author":"Allen","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bmc.2023.117368_b0100","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1089\/neu.2017.5271","article-title":"FGF21 Protects the blood-brain barrier by upregulating PPAR\u03b3 via FGFR1\/\u03b2-klotho after traumatic brain injury","volume":"35","author":"Chen","year":"2018","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.bmc.2023.117368_b0105","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.expneurol.2008.11.011","article-title":"Basic fibroblast growth factor-enhanced neurogenesis contributes to cognitive recovery in rats following traumatic brain injury","volume":"216","author":"Sun","year":"2009","journal-title":"Exp Neurol"},{"key":"10.1016\/j.bmc.2023.117368_b0110","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3892\/mmr.2013.1803","article-title":"Basic fibroblast growth factor increases the transplantation-mediated therapeutic effect of bone mesenchymal stem cells following traumatic brain injury","volume":"9","author":"Liu","year":"2014","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.bmc.2023.117368_b0115","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1750-1326-6-11","article-title":"Pathophysiology, treatment, and animal and cellular models of human ischemic stroke","volume":"6","author":"Woodruff","year":"2011","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.bmc.2023.117368_b0120","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1747-4949.2012.00839.x","article-title":"Pathophysiologic cascades in ischemic stroke","volume":"7","author":"Xing","year":"2012","journal-title":"Int J Stroke"},{"key":"10.1016\/j.bmc.2023.117368_b0125","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1212\/WNL.0b013e318297eecf","article-title":"Traumatic brain injury may be an independent risk factor for stroke","volume":"81","author":"Burke","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.bmc.2023.117368_b0130","doi-asserted-by":"crossref","first-page":"7533","DOI":"10.3390\/ijms21207533","article-title":"Spinal cord injury: pathophysiology, multimolecular interactions, and underlying recovery mechanisms","volume":"21","author":"Anjum","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2023.117368_b0135","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/B978-0-444-52892-6.00004-0","article-title":"The neuropathology of traumatic brain injury","volume":"127","author":"McKee","year":"2015","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.bmc.2023.117368_b0140","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.3390\/ijms23031851","article-title":"A review of the common neurodegenerative disorders: current therapeutic approaches and the potential role of nanotherapeutics","volume":"23","author":"Lamptey","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2023.117368_b0145","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40035-017-0088-2","article-title":"Pathological correlations between traumatic brain injury and chronic neurodegenerative diseases","volume":"6","author":"Cruz-Haces","year":"2017","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.bmc.2023.117368_b0150","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3390\/brainsci5020165","article-title":"Growth factors for the treatment of ischemic brain injury (growth factor treatment)","volume":"5","author":"Larpthaveesarp","year":"2015","journal-title":"Brain Sci"},{"key":"10.1016\/j.bmc.2023.117368_b0155","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1398-9995.1997.tb01247.x","article-title":"The expanding role of nerve growth factor: from neurotrophic activity to immunologic diseases","volume":"52","author":"Aloe","year":"1997","journal-title":"Allergy"},{"key":"10.1016\/j.bmc.2023.117368_b0160","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1006\/excr.1999.4705","article-title":"Neurotrophin signaling via Trks and p75","volume":"253","author":"Friedman","year":"1999","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.bmc.2023.117368_b0165","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1080\/02699052.2017.1376760","article-title":"Intranasal Nerve Growth Factor administration improves cerebral functions in a child with severe traumatic brain injury: a case report","volume":"31","author":"Chiaretti","year":"2017","journal-title":"Brain Inj"},{"key":"10.1016\/j.bmc.2023.117368_b0170","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1179\/016164107X247948","article-title":"Intraventricular nerve growth factor infusion improves cerebral blood flow and stimulates doublecortin expression in two infants with hypoxic-ischemic brain injury","volume":"30","author":"Chiaretti","year":"2008","journal-title":"Neurol Res"},{"key":"10.1016\/j.bmc.2023.117368_b0175","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/glia.23312","article-title":"NGF steers microglia toward a neuroprotective phenotype","volume":"66","author":"Rizzi","year":"2018","journal-title":"Glia"},{"key":"10.1016\/j.bmc.2023.117368_b0180","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00395-004-0502-7","article-title":"Stress alters vascular-endothelial growth factor expression in rat arteries: role of nerve growth factor","volume":"100","author":"Manni","year":"2005","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.bmc.2023.117368_b0185","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.754502","article-title":"Intranasal delivery of nerve growth factor in neurodegenerative diseases and neurotrauma","volume":"12","author":"Manni","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bmc.2023.117368_b0190","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/1479-5876-10-239","article-title":"Nerve growth factor: from the early discoveries to the potential clinical use","volume":"10","author":"Aloe","year":"2012","journal-title":"J Transl Med"},{"key":"10.1016\/j.bmc.2023.117368_b0195","doi-asserted-by":"crossref","first-page":"773","DOI":"10.4103\/1673-5374.354513","article-title":"Intranasal nerve growth factor for prevention and recovery of the outcomes of traumatic brain injury","volume":"18","author":"Manni","year":"2023","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.bmc.2023.117368_b0200","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/327239a0","article-title":"Scatter factor is a fibroblast-derived modulator of epithelial cell mobility","volume":"327","author":"Stoker","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2023.117368_b0205","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/6310","article-title":"Hepatocyte growth factor, a versatile signal for developing neurons","volume":"2","author":"Maina","year":"1999","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.bmc.2023.117368_b0210","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nrm3012","article-title":"MET signalling: principles and functions in development, organ regeneration and cancer","volume":"11","author":"Trusolino","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.bmc.2023.117368_b0215","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.683609","article-title":"HGF and MET: from brain development to neurological disorders","volume":"9","author":"Desole","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.bmc.2023.117368_b0220","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.brainres.2007.03.022","article-title":"Expression of hepatocyte growth factor and c-Met after spinal cord injury in rats","volume":"1151","author":"Shimamura","year":"2007","journal-title":"Brain Res"},{"key":"10.1016\/j.bmc.2023.117368_b0225","doi-asserted-by":"crossref","first-page":"e27706","DOI":"10.1371\/journal.pone.0027706","article-title":"Human hepatocyte growth factor promotes functional recovery in primates after spinal cord injury","volume":"6","author":"Kitamura","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bmc.2023.117368_b0230","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1089\/neu.2019.6854","article-title":"Phase I\/II study of intrathecal administration of recombinant human hepatocyte growth factor in patients with acute spinal cord injury: a double-blind, randomized clinical trial of safety and efficacy","volume":"37","author":"Nagoshi","year":"2020","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.bmc.2023.117368_b0235","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.3390\/ijms20051054","article-title":"Application of hepatocyte growth factor for acute spinal cord injury the road from basic studies to human treatment","volume":"20","author":"Kitamura","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2023.117368_b0240","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/jcph.1355","article-title":"Safety, tolerability, and pharmacodynamics of intrathecal injection of recombinant human HGF (KP-100) in subjects with amyotrophic lateral sclerosis: a phase I trial","volume":"59","author":"Warita","year":"2019","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.bmc.2023.117368_b0245","doi-asserted-by":"crossref","first-page":"6078","DOI":"10.3390\/ijms20236078","article-title":"Multipotent neurotrophic effects of hepatocyte growth factor in spinal cord injury","volume":"20","author":"Yamane","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2023.117368_b0250","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.expneurol.2011.10.021","article-title":"Hepatocyte growth factor reduces astrocytic scar formation and promotes axonal growth beyond glial scars after spinal cord injury","volume":"233","author":"Jeong","year":"2012","journal-title":"Exp Neurol"},{"key":"10.1016\/j.bmc.2023.117368_b0255","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.expneurol.2007.05.014","article-title":"CNS injury, glial scars, and inflammation: Inhibitory extracellular matrices and regeneration failure","volume":"209","author":"Fitch","year":"2008","journal-title":"Exp Neurol"},{"key":"10.1016\/j.bmc.2023.117368_b0260","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1179\/016164101101198659","article-title":"Hepatocyte growth factor reduces the infarct volume after transient focal cerebral ischemia in rats","volume":"23","author":"Tsuzuki","year":"2001","journal-title":"Neurol Res"},{"key":"10.1016\/j.bmc.2023.117368_b0265","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1126\/science.8493557","article-title":"GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons","volume":"260","author":"Lin","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.bmc.2023.117368_b0270","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1242\/jcs.00786","article-title":"Novel functions and signalling pathways for GDNF","volume":"116","author":"Sariola","year":"2003","journal-title":"J Cell Sci"},{"key":"10.1016\/j.bmc.2023.117368_b0275","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00441-020-03262-1","article-title":"Intracellular RET signaling pathways activated by GDNF","volume":"382","author":"Kawai","year":"2020","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.bmc.2023.117368_b0280","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrn812","article-title":"The GDNF family: signalling, biological functions and therapeutic value","volume":"3","author":"Airaksinen","year":"2002","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.bmc.2023.117368_b0285","doi-asserted-by":"crossref","first-page":"11702","DOI":"10.3390\/ijms222111702","article-title":"Mechanistic insight from preclinical models of Parkinson\u2019s disease could help redirect clinical trial efforts in GDNF therapy","volume":"22","author":"Delgado-Minjares","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2023.117368_b0290","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00441-020-03269-8","article-title":"GDNF clinical trials for Parkinson\u2019s disease: a critical human dimension","volume":"382","author":"Gash","year":"2020","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.bmc.2023.117368_b0295","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3233\/JPD-191576","article-title":"Extended treatment with glial cell line-derived neurotrophic factor in Parkinson\u2019s disease","volume":"9","author":"Whone","year":"2019","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.bmc.2023.117368_b0300","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1016\/j.febslet.2015.09.031","article-title":"Therapeutic potential of the endoplasmic reticulum located and secreted CDNF\/MANF family of neurotrophic factors in Parkinson\u2019s disease","volume":"589","author":"Voutilainen","year":"2015","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bmc.2023.117368_b0305","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/0963689719840290","article-title":"CDNF protein therapy in Parkinson's disease","volume":"28","author":"Huttunen","year":"2019","journal-title":"Cell Transplant"},{"key":"10.1016\/j.bmc.2023.117368_b0310","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1523\/JNEUROSCI.21-09-03024.2001","article-title":"Neuroprotection mediated by glial cell line-derived neurotrophic factor: involvement of a reduction of NMDA-induced calcium influx by the mitogen-activated protein kinase pathway","volume":"21","author":"Nicole","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.bmc.2023.117368_b0315","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/274818a0","article-title":"New factor released by cultured glioma cells supporting survival and growth of sensory neurones","volume":"274","author":"Barde","year":"1978","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2023.117368_b0320","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cell.2021.12.003","article-title":"BDNF signaling in context: From synaptic regulation to psychiatric disorders","volume":"185","author":"Wang","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.bmc.2023.117368_b0325","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.biocel.2007.06.010","article-title":"The p75 neurotrophin receptor","volume":"40","author":"Underwood","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.bmc.2023.117368_b0330","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1212\/WNL.52.7.1427","volume":"52","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.bmc.2023.117368_b0335","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40035-022-00279-0","article-title":"Brain-derived neurotrophic factor in Alzheimer\u2019s disease and its pharmaceutical potential","volume":"11","author":"Gao","year":"2022","journal-title":"Transl Neurodegen"},{"key":"10.1016\/j.bmc.2023.117368_b0340","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/(SICI)1097-4547(19960415)44:2<157::AID-JNR8>3.0.CO;2-C","article-title":"Increased expression of brain-derived neurotrophic factor but not neurotrophin-3 mRNA in rat brain after cortical impact injury","volume":"44","author":"Yang","year":"1996","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.bmc.2023.117368_b0345","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0006-8993(99)01501-2","article-title":"Regional changes in the expression of neurotrophic factors and their receptors following acute traumatic brain injury in the adult rat brain","volume":"833","author":"Oyesiku","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.bmc.2023.117368_b0350","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.3390\/ijms22073582","article-title":"The role of BDNF in experimental and clinical traumatic brain injury","volume":"22","author":"Gustafsson","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2023.117368_b0355","doi-asserted-by":"crossref","first-page":"3889300","DOI":"10.1155\/2022\/3889300","article-title":"Brain-derived neurotrophic factor and nerve growth factor therapeutics for brain injury: the current translational challenges in preclinical and clinical research","volume":"2022","author":"Sims","year":"2022","journal-title":"Neural Plast"},{"key":"10.1016\/j.bmc.2023.117368_b0360","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cytogfr.2004.03.007","article-title":"The PDGF family: four gene products form five dimeric isoforms","volume":"15","author":"Fredriksson","year":"2004","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.bmc.2023.117368_b0365","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cytogfr.2004.03.003","article-title":"PDGF signaling in cells and mice","volume":"15","author":"Tallquist","year":"2004","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.bmc.2023.117368_b0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2017.03.003","article-title":"PDGFs and their receptors","volume":"614","author":"Kazlauskas","year":"2017","journal-title":"Gene"},{"key":"10.1016\/j.bmc.2023.117368_b0375","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.mam.2018.01.006","article-title":"PDGF\/PDGFR axis in the neural systems","volume":"62","author":"Sil","year":"2018","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.bmc.2023.117368_b0380","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1172\/JCI79635","article-title":"Safety and tolerability of intracerebroventricular PDGF-BB in Parkinson\u2019s disease patients","volume":"125","author":"Paul","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bmc.2023.117368_b0385","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0169-328X(03)00085-8","article-title":"Time- and cell type-specific induction of platelet-derived growth factor receptor-\u03b2 during cerebral ischemia","volume":"113","author":"Renner","year":"2003","journal-title":"Mol Brain Res"},{"key":"10.1016\/j.bmc.2023.117368_b0390","doi-asserted-by":"crossref","first-page":"8054","DOI":"10.1074\/jbc.M805384200","article-title":"Platelet-derived growth factor selectively inhibits NR2B-containing N-methyl-D-aspartate receptors in CA1 hippocampal neurons","volume":"284","author":"Beazely","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2023.117368_b0395","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00441-003-0756-7","article-title":"Fibroblast growth factors and their receptors in the central nervous system","volume":"313","author":"Reuss von Bohlen und Halbach, O.","year":"2003","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.bmc.2023.117368_b0400","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1007\/s12035-021-02367-0","article-title":"Fibroblast growth factor signalling in the diseased nervous system","volume":"58","author":"Klimaschewski","year":"2021","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.bmc.2023.117368_b0405","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nrc2780","article-title":"Fibroblast growth factor signalling: from development to cancer","volume":"10","author":"Turner","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bmc.2023.117368_b0410","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1523\/JNEUROSCI.11-02-00412.1991","article-title":"Acidic and basic fibroblast growth factors in the nervous system: distribution and differential alteration of levels after injury of central versus peripheral nerve","volume":"11","author":"Eckenstein","year":"1991","journal-title":"J Neurosci"},{"key":"10.1016\/j.bmc.2023.117368_b0415","first-page":"910","article-title":"Acid fibroblast growth factor preserves blood-brain barrier integrity by activating the PI3K-Akt-Rac1 pathway and inhibiting RhoA following traumatic brain injury","volume":"9","author":"Wu","year":"2017","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.bmc.2023.117368_b0420","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12031-012-9706-8","article-title":"Combination of vascular endothelial and fibroblast growth factor 2 for induction of neurogenesis and angiogenesis after traumatic brain injury","volume":"47","author":"Thau-Zuchman","year":"2012","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.bmc.2023.117368_b0425","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3109\/08977194.2012.691478","article-title":"Neuroprotection by GDNF in the ischemic brain","volume":"30","author":"Duarte","year":"2012","journal-title":"Growth Factors"},{"key":"10.1016\/j.bmc.2023.117368_b0430","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3390\/brainsci8060109","article-title":"History of glial cell line-derived neurotrophic factor (GDNF) and its use for spinal cord injury repair","volume":"8","author":"Walker","year":"2018","journal-title":"Brain Sci"},{"key":"10.1016\/j.bmc.2023.117368_b0435","doi-asserted-by":"crossref","first-page":"1036907","DOI":"10.1155\/2019\/1036907","article-title":"Intracellular neuroprotective mechanisms in neuron-glial networks mediated by glial cell line-derived neurotrophic factor","volume":"2019","author":"Mitroshina","year":"2019","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.bmc.2023.117368_b0440","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1212\/WNL.60.1.69","article-title":"Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD","volume":"60","author":"Nutt","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.bmc.2023.117368_b0445","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nm850","article-title":"Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease","volume":"9","author":"Gill","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.bmc.2023.117368_b0450","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/ana.20737","article-title":"Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease","volume":"59","author":"Lang","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bmc.2023.117368_b0455","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/brain\/awz023","article-title":"Randomized trial of intermittent intraputamenal glial cell line-derived neurotrophic factor in Parkinson\u2019s disease","volume":"142","author":"Whone","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.bmc.2023.117368_b0460","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3233\/JPD-202004","article-title":"GDNF and Parkinson's disease: where next? A summary from a recent workshop","volume":"10","author":"Barker","year":"2020","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.bmc.2023.117368_b0465","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41419-022-05520-2","article-title":"Augmenting hematoma-scavenging capacity of innate immune cells by CDNF reduces brain injury and promotes functional recovery after intracerebral hemorrhage","volume":"14","author":"Tseng","year":"2023","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.bmc.2023.117368_b0470","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/14660820510028412","article-title":"Autonomic dysfunction in ALS: a preliminary study on the effects of intrathecal BDNF","volume":"6","author":"Beck","year":"2005","journal-title":"Amyotroph Lateral Scler"},{"key":"10.1016\/j.bmc.2023.117368_b0475","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1089\/neu.2010.1423","article-title":"Combined VEGF and PDGF treatment reduces secondary degeneration after spinal cord injury","volume":"29","author":"Lutton","year":"2011","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.bmc.2023.117368_b0480","article-title":"Platelet derived growth factor promotes the recovery of traumatic brain injury by inhibiting endoplasmic reticulum stress and autophagy-mediated pyroptosis","volume":"13","author":"Wu","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bmc.2023.117368_b0485","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.671131","article-title":"Roles of fibroblast growth factors and their therapeutic potential in treatment of ischemic stroke","volume":"12","author":"Dordoe","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bmc.2023.117368_b0490","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41392-022-00904-4","article-title":"Therapeutic peptides: current applications and future directions","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.bmc.2023.117368_b0495","doi-asserted-by":"crossref","first-page":"6071","DOI":"10.3390\/ijms22116071","article-title":"Peptides derived from growth factors to treat Alzheimer\u2019s disease","volume":"22","author":"Gascon","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2023.117368_b0500","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1002\/med.21721","article-title":"Low-molecular mimetics of nerve growth factor and brain-derived neurotrophic factor: design and pharmacological properties","volume":"41","author":"Gudasheva","year":"2021","journal-title":"Med Res Rev"},{"key":"10.1016\/j.bmc.2023.117368_b0505","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1091\/mbc.1.2.189","article-title":"The in vitro biological effect of nerve growth factor is inhibited by synthetic peptides","volume":"1","author":"Longo","year":"1990","journal-title":"Cell Regul"},{"key":"10.1016\/j.bmc.2023.117368_b0510","doi-asserted-by":"crossref","first-page":"29868","DOI":"10.1074\/jbc.M005071200","article-title":"Nerve growth factor (NGF) Loop 4 dimeric mimetics activate ERK and AKT and promote NGF-like neurotrophic effects","volume":"275","author":"Xie","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2023.117368_b0515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-4547(19970401)48:1<1::AID-JNR1>3.0.CO;2-K","article-title":"Synthetic NGF peptide derivatives prevent neuronal death via a p75 receptor-dependent mechanism","volume":"48","author":"Longo","year":"1997","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.bmc.2023.117368_b0520","doi-asserted-by":"crossref","first-page":"6564","DOI":"10.1074\/jbc.270.12.6564","article-title":"Small peptide mimics of nerve growth factor bind TrkA receptors and affect biological responses","volume":"270","author":"LeSauteur","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2023.117368_b0525","doi-asserted-by":"crossref","first-page":"9946","DOI":"10.1074\/jbc.275.14.9946","article-title":"Genuine monovalent ligands of TrkA nerve growth factor receptors reveal a novel pharmacological mechanism of action","volume":"275","author":"Maliartchouk","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2023.117368_b0530","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1021\/jm990441x","article-title":"Design and solution structure of functional peptide mimetics of nerve growth factor","volume":"43","author":"Beglova","year":"2000","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117368_b0535","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1134\/S160767291005011X","article-title":"Novel low-molecular-weight mimetics of the nerve growth factor","volume":"434","author":"Gudasheva","year":"2010","journal-title":"Dokl Biochem Biophys"},{"key":"10.1016\/j.bmc.2023.117368_b0540","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0736-5748(97)00032-4","article-title":"Effect of a long-term nerve growth factor treatment on body weight, blood pressure, and serum corticosterone in rats","volume":"15","author":"Taglialatela","year":"1997","journal-title":"Int J Dev Neurosci"},{"key":"10.1016\/j.bmc.2023.117368_b0545","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jpain.2005.08.003","article-title":"Time course and dose-dependence of nerve growth factor-induced secondary hyperalgesia in the mouse","volume":"7","author":"Hathway","year":"2006","journal-title":"J Pain"},{"key":"10.1016\/j.bmc.2023.117368_b0550","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12929-015-0198-z","article-title":"Dimeric dipeptide mimetics of the nerve growth factor Loop 4 and Loop 1 activate TRKA with different patterns of intracellular signal transduction","volume":"22","author":"Gudasheva","year":"2015","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.bmc.2023.117368_b0555","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1134\/S1607672920050075","article-title":"Dipeptide mimetics of different NGF and BDNF loops activate PLC-\u03b31","volume":"494","author":"Gudasheva","year":"2020","journal-title":"Dokl Biochem Biophys"},{"key":"10.1016\/j.bmc.2023.117368_b0560","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3109\/00207454.2014.935376","article-title":"Behavioral effect of dipeptide NGF mimetic GK-2 in an in vivo model of rat traumatic brain injury and its neuroprotective and regenerative properties in vitro","volume":"125","author":"Stelmashook","year":"2015","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.bmc.2023.117368_b0565","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10517-011-1202-6","article-title":"In vitro study of neuroprotective properties of GK-2, a new original nerve growth factor mimetic","volume":"150","author":"Antipova","year":"2011","journal-title":"Bull Exp Biol Med"},{"key":"10.1016\/j.bmc.2023.117368_b0570","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s10517-011-1388-7","article-title":"Neuroprotective effect of GK-2, a dipeptide mimetic of nerve growth factor, during experimental focal ischemia in middle cerebral artery basin","volume":"151","author":"Seredenin","year":"2011","journal-title":"Bull Exp Biol Med"},{"key":"10.1016\/j.bmc.2023.117368_b0575","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s10517-011-1161-y","article-title":"Neuroprotective and antiamnestic effect of nerve growth factor dipeptide mimetic GK-2 in experimental ischemic infarction of brain cortex","volume":"150","author":"Seredenin","year":"2011","journal-title":"Bull Exp Biol Med"},{"key":"10.1016\/j.bmc.2023.117368_b0580","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s10517-015-2989-3","article-title":"Effectiveness of GK-2, a nerve growth factor mimetic, in preventing post-resuscitation changes in the brain","volume":"159","author":"Zarzhetskii","year":"2015","journal-title":"Bull Exp Biol Med"},{"key":"10.1016\/j.bmc.2023.117368_b0585","doi-asserted-by":"crossref","first-page":"84","DOI":"10.32607\/20758251-2013-5-3-84-91","article-title":"Original nerve growth factor mimetic dipeptide GK-2 restores impaired cognitive functions in rat models of Alzheimer's disease","volume":"5","author":"Povarnina","year":"2013","journal-title":"Acta Nat"},{"key":"10.1016\/j.bmc.2023.117368_b0590","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/s10517-011-1417-6","article-title":"Antiparkinsonian properties of a nerve growth factor dipeptide mimetic GK-2 in in vivo experiments","volume":"151","author":"Povarnina","year":"2011","journal-title":"Bull Exp Biol Med"},{"key":"10.1016\/j.bmc.2023.117368_b0595","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1134\/S1068162017030050","article-title":"Design, synthesis, and neuroprotective effects of a dimeric dipeptide mimetic of the third loop of the nerve growth factor","volume":"43","author":"Gudasheva","year":"2017","journal-title":"Russ J Bioorg Chem"},{"key":"10.1016\/j.bmc.2023.117368_b0600","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0026-895X(24)23211-9","article-title":"A designed peptidomimetic agonistic ligand of TrkA nerve growth factor receptors","volume":"57","author":"Maliartchouk","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bmc.2023.117368_b0605","doi-asserted-by":"crossref","first-page":"8009","DOI":"10.1523\/JNEUROSCI.1508-04.2004","article-title":"Long-lasting rescue of age-associated deficits in cognition and the CNS cholinergic phenotype by a partial agonist peptidomimetic ligand of TrkA","volume":"24","author":"Bruno","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.bmc.2023.117368_b0610","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/dneu.20360","article-title":"Neurotrophic rationale in glaucoma: A TrkA agonist, but not NGF or a p75 antagonist, protects retinal ganglion cells in vivo","volume":"67","author":"Shi","year":"2007","journal-title":"Dev Neurobiol"},{"key":"10.1016\/j.bmc.2023.117368_b0615","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1124\/mol.111.071332","article-title":"Ligand-dependent TrkA activity in brain differentially affects spatial learning and long-term memory","volume":"80","author":"Aboulkassim","year":"2011","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bmc.2023.117368_b0620","doi-asserted-by":"crossref","unstructured":"Brahimi F. et al. A monovalent agonist of TrkA tyrosine kinase receptors can be converted into a bivalent antagonist. Biochim Biophys Acta (BBA) - General Subjects 1800; 2010:1018-26. 10.1016\/j.bbagen.2010.06.007.","DOI":"10.1016\/j.bbagen.2010.06.007"},{"key":"10.1016\/j.bmc.2023.117368_b0625","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.chembiol.2005.06.015","article-title":"Selective small molecule peptidomimetic ligands of TrkC and TrkA receptors afford discrete or complete neurotrophic activities","volume":"12","author":"Zaccaro","year":"2005","journal-title":"Chem Biol"},{"key":"10.1016\/j.bmc.2023.117368_b0630","article-title":"New, potent, small molecule agonists of tyrosine kinase receptors attenuate dry eye disease","volume":"9","author":"Yu","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.bmc.2023.117368_b0635","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1002\/chem.201002294","article-title":"The inorganic perspective of nerve growth factor: interactions of Cu2+ and Zn2+ with the N-terminus fragment of nerve growth factor encompassing the recognition domain of the TrkA receptor","volume":"17","author":"Travaglia","year":"2011","journal-title":"Chem A Eur J"},{"key":"10.1016\/j.bmc.2023.117368_b0640","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1021\/acschemneuro.5b00069","article-title":"A small linear peptide encompassing the NGF N-terminus partly mimics the biological activities of the entire neurotrophin in PC12 cells","volume":"6","author":"Travaglia","year":"2015","journal-title":"ACS Chem Nerosci"},{"key":"10.1016\/j.bmc.2023.117368_b0645","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3389\/fnins.2016.00569","article-title":"The inorganic side of NGF: copper(II) and zinc(II) affect the NGF mimicking signaling of the N-terminus peptides encompassing the recognition domain of TrkA receptor","volume":"10","author":"Pandini","year":"2016","journal-title":"Front Neurosci"},{"key":"10.1016\/j.bmc.2023.117368_b0650","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3390\/biom10020216","article-title":"hNGF peptides elicit the NGF-TrkA signalling pathway in cholinergic neurons and retain full neurotrophic activity in the DRG assay","volume":"10","author":"Triaca","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.bmc.2023.117368_b0655","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1523\/JNEUROSCI.5201-07.2008","article-title":"A new nerve growth factor-mimetic peptide active on neuropathic pain in rats","volume":"28","author":"Colangelo","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.bmc.2023.117368_b0660","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.biotechadv.2011.05.008","article-title":"BB14, a Nerve Growth Factor (NGF)-like peptide shown to be effective in reducing reactive astrogliosis and restoring synaptic homeostasis in a rat model of peripheral nerve injury","volume":"30","author":"Cirillo","year":"2012","journal-title":"Biotechnol Adv"},{"key":"10.1016\/j.bmc.2023.117368_b0665","doi-asserted-by":"crossref","first-page":"e0152750","DOI":"10.1371\/journal.pone.0152750","article-title":"Modulation of matrix metalloproteinases activity in the ventral horn of the spinal cord re-stores neuroglial synaptic homeostasis and neurotrophic support following peripheral nerve injury","volume":"11","author":"Cirillo","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bmc.2023.117368_b0670","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1083\/jcb.136.2.389","article-title":"Two peptides derived from the nerve growth factor precursor are biologically active","volume":"136","author":"Dicou","year":"1997","journal-title":"J Cell Biol"},{"key":"10.1016\/j.bmc.2023.117368_b0675","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0165-3806(97)00005-9","article-title":"Two peptides derived from the nerve growth factor precursor enhance cholinergic enzyme activities in vivo","volume":"99","author":"Clos","year":"1997","journal-title":"Dev Brain Res"},{"key":"10.1016\/j.bmc.2023.117368_b0680","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.bbrc.2006.06.171","article-title":"Multiple biological activities for two peptides derived from the nerve growth factor precursor","volume":"347","author":"Dicou","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bmc.2023.117368_b0685","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0165-3806(98)00141-2","article-title":"Somatostatin enhances neurite outgrowth in PC12 cells","volume":"111","author":"Traina","year":"1998","journal-title":"Dev Brain Res"},{"key":"10.1016\/j.bmc.2023.117368_b0690","doi-asserted-by":"crossref","first-page":"15094","DOI":"10.1021\/jacs.5b10779","article-title":"Orthogonal cysteine-penicillamine disulfide pairing for directing the oxidative folding of peptides","volume":"137","author":"Zheng","year":"2015","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2023.117368_b0695","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.peptides.2018.04.012","article-title":"A synthetic snake-venom-based tripeptide (Glu-Val-Trp) protects PC12 cells from MPP+ toxicity by activating the NGF-signaling pathway","volume":"104","author":"Bernardes","year":"2018","journal-title":"Peptides"},{"key":"10.1016\/j.bmc.2023.117368_b0700","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1091\/mbc.11.4.1487","article-title":"A trypanosomal protein synergizes with the cytokines ciliary neurotrophic factor and leukemia inhibitory factor to prevent apoptosis of neuronal cells","volume":"11","author":"Chuenkova","year":"2000","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.bmc.2023.117368_b0705","doi-asserted-by":"crossref","first-page":"15685","DOI":"10.1021\/bi0512039","article-title":"A synthetic peptide modeled on PDNF, Chagas' disease parasite neurotrophic factor, promotes survival and differentiation of neuronal cells through TrkA receptor","volume":"44","author":"Chuenkova","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmc.2023.117368_b0710","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0092-8674(92)90413-7","article-title":"Disruption of the low affinity receptor-binding site in NGF allows neuronal survival and differentiation by binding to the trk gene product","volume":"69","author":"Ib\u00e1\u00f1ez","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.bmc.2023.117368_b0715","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0041-0101(03)00225-3","article-title":"Characterization of nerve growth factors (NGFs) from snake venoms by use of a novel, quantitative bioassay utilizing pheochromocytoma (PC12) cells overexpressing human trkA receptors","volume":"42","author":"Katzir","year":"2003","journal-title":"Toxicon"},{"key":"10.1016\/j.bmc.2023.117368_b0720","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0896-6273(00)80084-7","article-title":"TrkA activation is sufficient to rescue axotomized cholinergic neurons","volume":"16","author":"Lucidi-Phillipi","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.bmc.2023.117368_b0725","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1523\/JNEUROSCI.16-04-01308.1996","article-title":"Potent human p140-TrkA agonists derived from an anti-receptor monoclonal antibody","volume":"16","author":"LeSauteur","year":"1996","journal-title":"J Neurosci"},{"key":"10.1016\/j.bmc.2023.117368_b0730","doi-asserted-by":"crossref","first-page":"16329","DOI":"10.1073\/pnas.0706662104","article-title":"Gambogic amide, a selective agonist for TrkA receptor that possesses robust neurotrophic activity, prevents neuronal cell death","volume":"104","author":"Jang","year":"2007","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bmc.2023.117368_b0735","first-page":"94","article-title":"The selective TrkA agonist, gambogic amide, promotes osteoblastic differentiation and improves fracture healing in mice","volume":"19","author":"Johnstone","year":"2019","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"10.1016\/j.bmc.2023.117368_b0740","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/02699052.2017.1394492","article-title":"Gambogic amide, a selective TrkA agonist, does not improve outcomes from traumatic brain injury in mice","volume":"32","author":"Johnstone","year":"2018","journal-title":"Brain Inj"},{"key":"10.1016\/j.bmc.2023.117368_b0745","doi-asserted-by":"crossref","first-page":"6373","DOI":"10.1038\/ncomms7373","article-title":"Artificial human Met agonists based on macrocycle scaffolds","volume":"6","author":"Ito","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmc.2023.117368_b0750","doi-asserted-by":"crossref","first-page":"16492","DOI":"10.1038\/s41598-018-34835-4","article-title":"Cellular signaling and gene expression profiles evoked by a bivalent macrocyclic peptide that serves as an artificial MET receptor agonist","volume":"8","author":"Miao","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2023.117368_b0755","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s41551-022-00955-6","article-title":"Designing receptor agonists with enhanced pharmacokinetics by grafting macrocyclic peptides into fragment crystallizable regions","volume":"7","author":"Sakai","year":"2023","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.bmc.2023.117368_b0760","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s42003-022-03015-6","article-title":"Single-chain tandem macrocyclic peptides as a scaffold for growth factor and cytokine mimetics","volume":"5","author":"Ito","year":"2022","journal-title":"Commun Biol"},{"key":"10.1016\/j.bmc.2023.117368_b0765","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1124\/jpet.114.218735","article-title":"The procognitive and synaptogenic effects of angiotensin IV-derived peptides are dependent on activation of the hepatocyte growth factor\/c-Met system","volume":"351","author":"Benoist","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bmc.2023.117368_b0770","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1124\/jpet.112.199497","article-title":"Evaluation of metabolically stabilized angiotensin IV analogs as procognitive\/antidementia agents","volume":"344","author":"McCoy","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bmc.2023.117368_b0775","doi-asserted-by":"crossref","first-page":"40362","DOI":"10.1074\/jbc.M110.179721","article-title":"Allosteric peptide activators of pro-hepatocyte growth factor stimulate Met signaling","volume":"285","author":"Landgraf","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2023.117368_b0780","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.febslet.2013.03.036","article-title":"WKYMVm-induced cross-talk between FPR2 and HGF receptor in human prostate epithelial cell line PNT1A","volume":"587","author":"Cattaneo","year":"2013","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bmc.2023.117368_b0785","article-title":"Therapeutic potential of WKYMVm in diseases","volume":"13","author":"Ma","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bmc.2023.117368_b0790","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1016\/j.ekir.2020.09.031","article-title":"Hepatocyte growth factor mimetic ANG-3777 for cardiac surgery-associated acute kidney injury","volume":"5","author":"Ayad","year":"2020","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.bmc.2023.117368_b0795","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ekir.2020.11.001","article-title":"Phase 3 trial design of the hepatocyte growth factor mimetic ANG-3777 in renal transplant recipients with delayed graft function","volume":"6","author":"Vincenti","year":"2021","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.bmc.2023.117368_b0800","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/anie.201508572","article-title":"Oligonucleotide-based mimetics of hepatocyte growth factor","volume":"55","author":"Ueki","year":"2016","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.bmc.2023.117368_b0805","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3390\/cancers12030741","article-title":"Molecular engineering strategies tailoring the apoptotic response to a MET therapeutic antibody","volume":"12","author":"Modica","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.bmc.2023.117368_b0810","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/lt.26301","article-title":"A mesenchymal-epithelial transition factor-agonistic antibody accelerates cirrhotic liver regeneration and improves mouse survival following partial hepatectomy","volume":"28","author":"Ma","year":"2022","journal-title":"Liver Transpl"},{"key":"10.1016\/j.bmc.2023.117368_b0815","article-title":"A single injection of CM1021, a long half-life hepatocyte growth factor mimetic, increases liver mass in mice","volume":"28","author":"Kelly","year":"2021","journal-title":"Biochem Biophys Rep"},{"key":"10.1016\/j.bmc.2023.117368_b0820","doi-asserted-by":"crossref","unstructured":"Jones DS, Tsai P-C, Cochran JR. Engineering hepatocyte growth factor fragments with high stability and activity as Met receptor agonists and antagonists. Proc Natl Acad Sci 2011;108:13035\u201340. 10.1073\/pnas.1102561108.","DOI":"10.1073\/pnas.1102561108"},{"key":"10.1016\/j.bmc.2023.117368_b0825","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.1016\/j.febslet.2014.11.018","article-title":"An engineered dimeric fragment of hepatocyte growth factor is a potent c-MET agonist","volume":"588","author":"Liu","year":"2014","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bmc.2023.117368_b0830","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1039\/C4SC03856H","article-title":"Semi-synthesis of a HGF\/SF kringle one (K1) domain scaffold generates a potent in vivo MET receptor agonist","volume":"6","author":"Simonneau","year":"2015","journal-title":"Chem Sci"},{"key":"10.1016\/j.bmc.2023.117368_b0835","doi-asserted-by":"crossref","first-page":"e202201424","DOI":"10.26508\/lsa.202201424","article-title":"Dimerization of kringle 1 domain from hepatocyte growth factor\/scatter factor provides a potent MET receptor agonist","volume":"5","author":"Giovanni de","year":"2022","journal-title":"Life Science Alliance"},{"key":"10.1016\/j.bmc.2023.117368_b0840","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00403-018-1870-4","article-title":"Topical treatment with the bacterium-derived c-Met agonist InlB321\/15 accelerates healing in the abrasion wound mouse model","volume":"310","author":"Chalenko","year":"2018","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.bmc.2023.117368_b0845","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0169-328X(95)00075-4","article-title":"Localization and functional coupling of HGF and c-Met\/HGF receptor in rat brain: implication as neurotrophic factor","volume":"32","author":"Honda","year":"1995","journal-title":"Mol Brain Res"},{"key":"10.1016\/j.bmc.2023.117368_b0850","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.coph.2013.05.018","article-title":"Targeting MET: why, where and how?","volume":"13","author":"Ghiso","year":"2013","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.bmc.2023.117368_b0855","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3389\/fcell.2020.00152","article-title":"Targeting the HGF\/MET axis in cancer therapy: challenges in resistance and opportunities for improvement","volume":"8","author":"Huang","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.bmc.2023.117368_b0860","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/s41589-019-0285-7","article-title":"Macrocyclic peptide-based inhibition and imaging of hepatocyte growth factor","volume":"15","author":"Sakai","year":"2019","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.bmc.2023.117368_b0865","doi-asserted-by":"crossref","first-page":"30088","DOI":"10.18632\/oncotarget.3937","article-title":"The HGF inhibitory peptide HGP-1 displays promising in vitro and in vivo efficacy for targeted cancer therapy","volume":"6","author":"Chen","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bmc.2023.117368_b0870","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1080\/15384047.2019.1647051","article-title":"C7 peptide inhibits hepatocellular carcinoma metastasis by targeting the HGF\/c-Met signaling pathway","volume":"20","author":"Zhao","year":"2019","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.bmc.2023.117368_b0875","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.1158\/1078-0432.CCR-07-0035","article-title":"Identification of a Met-binding peptide from a phage display library","volume":"13","author":"Zhao","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bmc.2023.117368_b0880","doi-asserted-by":"crossref","first-page":"29274","DOI":"10.1074\/jbc.274.41.29274","article-title":"A Peptide representing the carboxyl-terminal tail of the met receptor inhibits kinase activity and invasive growth","volume":"274","author":"Bardelli","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2023.117368_b0885","doi-asserted-by":"crossref","first-page":"5286","DOI":"10.1038\/onc.2010.267","article-title":"Cell delivery of Met docking site peptides inhibit angiogenesis and vascular tumor growth","volume":"29","author":"Cantelmo","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.bmc.2023.117368_b0890","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.peptides.2013.12.007","article-title":"Dynamic changes in dopamine neuron function after DNSP-11 treatment: effects in vivo and increased ERK 1\/2 phosphorylation in vitro","volume":"54","author":"Fuqua","year":"2014","journal-title":"Peptides"},{"key":"10.1016\/j.bmc.2023.117368_b0895","doi-asserted-by":"crossref","first-page":"e9752","DOI":"10.1371\/journal.pone.0009752","article-title":"Dopamine neuron stimulating actions of a GDNF propeptide","volume":"5","author":"Bradley","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bmc.2023.117368_b0900","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jneumeth.2015.05.006","article-title":"Methodology and effects of repeated intranasal delivery of DNSP-11 in a rat model of Parkinson's disease","volume":"251","author":"Stenslik","year":"2015","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.bmc.2023.117368_b0905","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.expneurol.2007.12.018","article-title":"A proGDNF-related peptide BEP increases synaptic excitation in rat hippocampus","volume":"210","author":"Immonen","year":"2008","journal-title":"Exp Neurol"},{"key":"10.1016\/j.bmc.2023.117368_b0910","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jneumeth.2018.03.006","article-title":"Methodology and effects of repeated intranasal delivery of DNSP-11 in awake Rhesus macaques","volume":"303","author":"Stenslik","year":"2018","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.bmc.2023.117368_b0915","doi-asserted-by":"crossref","first-page":"11360","DOI":"10.1523\/JNEUROSCI.3239-09.2009","article-title":"Role of glial cell line-derived neurotrophic Factor (GDNF)-neural cell adhesion molecule (NCAM) interactions in induction of neurite outgrowth and identification of a binding site for NCAM in the heel region of GDNF","volume":"29","author":"Janne","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.bmc.2023.117368_b0920","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0092-8674(03)00435-5","article-title":"The Neural cell adhesion molecule NCAM is an alternative signaling receptor for GDNF family ligands","volume":"113","author":"Paratcha","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.bmc.2023.117368_b0925","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0969-2126(03)00096-0","article-title":"Structural basis for a direct interaction between FGFR1 and NCAM and evidence for a regulatory role of ATP","volume":"11","author":"Kiselyov","year":"2003","journal-title":"Structure"},{"key":"10.1016\/j.bmc.2023.117368_b0930","doi-asserted-by":"crossref","first-page":"906","DOI":"10.5966\/sctm.2013-0072","article-title":"Delivery of differentiation factors by mesoporous silica particles assists advanced differentiation of transplanted murine embryonic stem cells","volume":"2","author":"Garcia-Bennett","year":"2013","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.bmc.2023.117368_b0935","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3389\/fnmol.2019.00047","article-title":"Artemin and an artemin-derived peptide, artefin, induce neuronal survival, and differentiation through Ret and NCAM","volume":"12","author":"Ilieva","year":"2019","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.bmc.2023.117368_b0940","doi-asserted-by":"crossref","first-page":"6575","DOI":"10.3390\/ijms21186575","article-title":"Small molecules and peptides targeting glial cell line-derived neurotrophic factor receptors for the treatment of neurodegeneration","volume":"21","author":"Sidorova","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2023.117368_b0945","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nature05957","article-title":"Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo","volume":"448","author":"Lindholm","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2023.117368_b0950","unstructured":"Saarma M, Airavaara M, Voutilainen M, Yu LY, Lindahl M. C-terminal cdnf and manf fragments, pharmaceutical compositions comprising same and uses thereof. WO2018202957A1; 2018."},{"key":"10.1016\/j.bmc.2023.117368_b0955","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1046\/j.1471-4159.1998.70041712.x","article-title":"Structure-activity relationships of conformationally constrained peptide analogues of Loop 2 of brain-derived neurotrophic factor","volume":"70","author":"O'Leary","year":"1998","journal-title":"J Neurochem"},{"key":"10.1016\/j.bmc.2023.117368_b0960","doi-asserted-by":"crossref","first-page":"25738","DOI":"10.1074\/jbc.M303209200","article-title":"Design of potent peptide mimetics of brain-derived neurotrophic factor","volume":"278","author":"O'Leary","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2023.117368_b0965","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/psc.760","article-title":"Novel monocyclic and bicyclic loop mimetics of brain-derived neurotrophic factor","volume":"12","author":"Fletcher","year":"2006","journal-title":"J Pept Sci"},{"key":"10.1016\/j.bmc.2023.117368_b0970","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.mcn.2014.10.002","article-title":"TDP6, a brain-derived neurotrophic factor-based trkB peptide mimetic, promotes oligodendrocyte myelination","volume":"63","author":"Wong","year":"2014","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.bmc.2023.117368_b0975","doi-asserted-by":"crossref","first-page":"7088","DOI":"10.1523\/JNEUROSCI.0487-18.2018","article-title":"Targeting TrkB with a brain-derived neurotrophic factor mimetic promotes myelin repair in the brain","volume":"38","author":"Fletcher","year":"2018","journal-title":"J Neurosci"},{"key":"10.1016\/j.bmc.2023.117368_b0980","doi-asserted-by":"crossref","first-page":"33375","DOI":"10.1074\/jbc.M802789200","article-title":"Design of a conformationally defined and proteolytically stable circular mimetic of brain-derived neurotrophic factor","volume":"283","author":"Fletcher","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2023.117368_b0985","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/jnc.12168","article-title":"A small peptide mimetic of brain-derived neurotrophic factor promotes peripheral myelination","volume":"125","author":"Xiao","year":"2013","journal-title":"J Neurochem"},{"key":"10.1016\/j.bmc.2023.117368_b0990","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1021\/acs.nanolett.8b02317","article-title":"Supramolecular nanostructure activates TrkB receptor signaling of neuronal cells by mimicking brain-derived neurotrophic factor","volume":"18","author":"Edelbrock","year":"2018","journal-title":"Nano Lett"},{"key":"10.1016\/j.bmc.2023.117368_b0995","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1016\/j.bmc.2009.02.053","article-title":"Modified low molecular weight cyclic peptides as mimetics of BDNF with improved potency, proteolytic stability and transmembrane passage in vitro","volume":"17","author":"Fletcher","year":"2009","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2023.117368_b1000","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1134\/S1068162012030053","article-title":"Design and synthesis of dipeptide mimetics of the brain-derived neurotrophic factor","volume":"38","author":"Gudasheva","year":"2012","journal-title":"Russ J Bioorg Chem"},{"key":"10.1016\/j.bmc.2023.117368_b1005","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1134\/S1607672913040121","article-title":"Brain-derived neurotrophic factor loop 4 dipeptide mimetic GSB-106 activates TrkB, Erk, and Akt and promotes neuronal survival in vitro","volume":"451","author":"Gudasheva","year":"2013","journal-title":"Dokl Biochem Biophys"},{"key":"10.1016\/j.bmc.2023.117368_b1010","doi-asserted-by":"crossref","first-page":"7781","DOI":"10.1038\/s41598-021-87435-0","article-title":"Dimeric mimetic of BDNF loop 4 promotes survival of serum-deprived cell through TrkB-dependent apoptosis suppression","volume":"11","author":"Zainullina","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2023.117368_b1015","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.2147\/DDDT.S118768","article-title":"Mimetics of brain-derived neurotrophic factor loops 1 and 4 are active in a model of ischemic stroke in rats","volume":"10","author":"Gudasheva","year":"2016","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.bmc.2023.117368_b1020","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s10517-020-04869-8","article-title":"Behavioral effects of dimeric dipeptide BDNF Mimetic GSB-106 in a rat model of depressive-like state","volume":"169","author":"Garibova","year":"2020","journal-title":"Bull Exp Biol Med"},{"key":"10.1016\/j.bmc.2023.117368_b1025","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3390\/biom11020252","article-title":"Low-molecular weight BDNF mimetic, dimeric dipeptide GSB-106, reverses depressive symptoms in mouse chronic social defeat stress","volume":"11","author":"Gudasheva","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.bmc.2023.117368_b1030","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s11094-018-1896-0","article-title":"Synthesis and biological properties of a new dipeptide mimetic of brain-derived neurotrophic factor loop 2","volume":"52","author":"Sazonova","year":"2018","journal-title":"Pharm Chem J"},{"key":"10.1016\/j.bmc.2023.117368_b1035","doi-asserted-by":"crossref","first-page":"e53596","DOI":"10.1371\/journal.pone.0053596","article-title":"Neurogenic and neurotrophic effects of BDNF peptides in mouse hippocampal primary neuronal cell cultures","volume":"8","author":"Cardenas-Aguayo d. C., Kazim, S. F., Grundke-Iqbal, I. & Iqbal, K.","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bmc.2023.117368_b1040","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1021\/acschemneuro.2c00463","article-title":"Neurotrophic activity and its modulation by zinc ion of a dimeric peptide mimicking the brain-derived neurotrophic factor N-terminal region","volume":"13","author":"Russo","year":"2022","journal-title":"ACS Chem Nerosci"},{"key":"10.1016\/j.bmc.2023.117368_b1045","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/jnr.22285","article-title":"Peptides derived from the solvent-exposed loops 3 and 4 of BDNF bind TrkB and p75NTR receptors and stimulate neurite outgrowth and survival","volume":"88","author":"Fobian","year":"2010","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.bmc.2023.117368_b1050","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.1007\/s12274-018-2041-9","article-title":"A neurotrophic peptide-functionalized self-assembling peptide nanofiber hydrogel enhances rat sciatic nerve regeneration","volume":"11","author":"Lu","year":"2018","journal-title":"Nano Res"},{"key":"10.1016\/j.bmc.2023.117368_b1055","doi-asserted-by":"crossref","first-page":"19943","DOI":"10.1039\/C9NR04521J","article-title":"Synergistic effects of dual-presenting VEGF- and BDNF-mimetic peptide epitopes from self-assembling peptide hydrogels on peripheral nerve regeneration","volume":"11","author":"Lu","year":"2019","journal-title":"Nanoscale"},{"key":"10.1016\/j.bmc.2023.117368_b1060","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1007\/s12274-021-3684-5","article-title":"Crosstalk between PC12 cells and endothelial cells in an artificial neurovascular niche constructed by a dual-functionalized self-assembling peptide nanofiber hydrogel","volume":"15","author":"Zhang","year":"2022","journal-title":"Nano Res"},{"key":"10.1016\/j.bmc.2023.117368_b1065","doi-asserted-by":"crossref","first-page":"8227","DOI":"10.7150\/thno.44276","article-title":"Self-assembling peptide hydrogels functionalized with LN- and BDNF- mimicking epitopes synergistically enhance peripheral nerve regeneration","volume":"10","author":"Yang","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.bmc.2023.117368_b1070","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1021\/acsbiomaterials.8b00536","article-title":"Bioactive self-assembling peptide hydrogels functionalized with brain-derived neurotrophic factor and nerve growth factor mimicking peptides synergistically promote peripheral nerve regeneration","volume":"4","author":"Lu","year":"2018","journal-title":"ACS Biomater Sci Eng"},{"key":"10.1016\/j.bmc.2023.117368_b1075","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bbrc.2016.12.186","article-title":"Generation of a novel artificial TrkB agonist, BM17d99, using T7 phage-displayed random peptide libraries","volume":"483","author":"Ohnishi","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bmc.2023.117368_b1080","doi-asserted-by":"crossref","first-page":"7612","DOI":"10.1002\/jcb.28036","article-title":"Peptide selected by phage display increases survival of SH-SY5Y neurons comparable to brain-derived neurotrophic factor","volume":"120","author":"Nafian","year":"2019","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.bmc.2023.117368_b1085","unstructured":"PeptiGrowth. Fully-Chemically Synthesized Peptide with Activity Equivalent to BDNF; 2023. https:\/\/peptigrowth.com\/en\/products\/pg-003\/. [accessed 05 April 2023]."},{"key":"10.1016\/j.bmc.2023.117368_b1090","volume":"US20210317233A1","author":"Suga","year":"2021","journal-title":"Super versatile method for imparting new binding specificity to antibody"},{"key":"10.1016\/j.bmc.2023.117368_b1095","doi-asserted-by":"crossref","unstructured":"Jang S-W et al. A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone. Proc Natl Acad Sci 2010;107:2687\u201392. 10.1073\/pnas.0913572107.","DOI":"10.1073\/pnas.0913572107"},{"key":"10.1016\/j.bmc.2023.117368_b1100","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1021\/acschemneuro.1c00181","article-title":"Optimized TrkB agonist ameliorates Alzheimer\u2019s disease pathologies and improves cognitive functions via inhibiting delta-secretase","volume":"12","author":"Chen","year":"2021","journal-title":"ACS Chem Nerosci"},{"key":"10.1016\/j.bmc.2023.117368_b1105","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1172\/JCI41356","article-title":"Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents","volume":"120","author":"Massa","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bmc.2023.117368_b1110","doi-asserted-by":"crossref","first-page":"7568","DOI":"10.18632\/aging.204306","article-title":"Novel TRKB agonists activate TRKB and downstream ERK and AKT signaling to protect A\u03b2-GFP SH-SY5Y cells against A\u03b2 toxicity","volume":"14","author":"Chiu","year":"2022","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bmc.2023.117368_b1115","doi-asserted-by":"crossref","first-page":"e87923","DOI":"10.1371\/journal.pone.0087923","article-title":"A monoclonal antibody TrkB receptor agonist as a potential therapeutic for Huntington\u2019s disease","volume":"9","author":"Todd","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bmc.2023.117368_b1120","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104590","article-title":"TrkB agonistic antibodies superior to BDNF: Utility in treating motoneuron degeneration","volume":"132","author":"Guo","year":"2019","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.bmc.2023.117368_b1125","doi-asserted-by":"crossref","first-page":"9394","DOI":"10.1523\/JNEUROSCI.1118-06.2006","article-title":"Novel agonist monoclonal antibodies activate TrkB receptors and demonstrate potent neurotrophic activities","volume":"26","author":"Ming","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.bmc.2023.117368_b1130","doi-asserted-by":"crossref","first-page":"eaal1670","DOI":"10.1126\/scisignal.aal1670","article-title":"Multiplex quantitative assays indicate a need for reevaluating reported small-molecule TrkB agonists","volume":"10","author":"Boltaev","year":"2017","journal-title":"Sci Signal"},{"key":"10.1016\/j.bmc.2023.117368_b1135","first-page":"2031","article-title":"Targeting the BDNF\/TrkB pathway for the treatment of tumors","volume":"17","author":"Meng","year":"2019","journal-title":"Oncol Lett"},{"key":"10.1016\/j.bmc.2023.117368_b1140","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.bmcl.2011.10.107","article-title":"Cyclic amino acid linkers stabilizing key loops of brain derived neurotrophic factor","volume":"22","author":"Baeza","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2023.117368_b1145","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF03182687","article-title":"Selection of trkB-binding peptides from a phage-displayed random peptide library","volume":"46","author":"Ma","year":"2003","journal-title":"Sci China C Life Sci"},{"key":"10.1016\/j.bmc.2023.117368_b1150","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2020.128309","article-title":"PDGF-mimicking supramolecular nanofibers for ionizing radiation-induced injury repair","volume":"410","author":"Shang","year":"2021","journal-title":"Chem Eng J"},{"key":"10.1016\/j.bmc.2023.117368_b1155","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1021\/acsnano.2c12017","article-title":"Supramolecular hydrogel microspheres of platelet-derived growth factor mimetic peptide promote recovery from spinal cord injury","volume":"17","author":"Wu","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.bmc.2023.117368_b1160","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/08977190701553449","article-title":"A synthetic, bioactive PDGF mimetic with binding to both \u03b1-PDGF and \u03b2-PDGF receptors","volume":"25","author":"Lin","year":"2007","journal-title":"Growth Factors"},{"key":"10.1016\/j.bmc.2023.117368_b1165","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0014-5793(97)00885-5","article-title":"Identification of a cyclic peptide inhibitor of platelet-derived growth factor-BB receptor-binding and mitogen-induced DNA synthesis in human fibroblasts","volume":"413","author":"Brennand","year":"1997","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bmc.2023.117368_b1170","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0014-5793(97)01446-4","article-title":"A cyclic peptide analogue of loop III of PDGF-BB causes apoptosis in human fibroblasts","volume":"419","author":"Brennand","year":"1997","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bmc.2023.117368_b1175","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/S0006-2952(03)00445-3","article-title":"The preferential homing of a platelet derived growth factor receptor-recognizing macromolecule to fibroblast-like cells in fibrotic tissue","volume":"66","author":"Beljaars","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bmc.2023.117368_b1180","doi-asserted-by":"crossref","first-page":"16581","DOI":"10.1016\/S0021-9258(18)42042-X","article-title":"Identification of a peptide antagonist for platelet-derived growth factor","volume":"267","author":"Engstr\u00f6m","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2023.117368_b1185","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1089\/wound.2019.1051","article-title":"Development of a peptide derived from platelet-derived growth factor (PDGF-BB) into a potential drug candidate for the treatment of wounds","volume":"9","author":"Deptu\u0142a","year":"2019","journal-title":"Adv Wound Care"},{"key":"10.1016\/j.bmc.2023.117368_b1190","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1073\/pnas.85.7.2324","article-title":"Receptor- and heparin-binding domains of basic fibroblast growth factor","volume":"85","author":"Baird","year":"1988","journal-title":"PNAS"},{"key":"10.1016\/j.bmc.2023.117368_b1195","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/jcp.1041490322","article-title":"Biologically active synthetic fragments of human basic fibroblast growth factor (bFGF): Identification of two Asp-Gly-Arg-Containing domains involved in the mitogenic activity of bFGF in endothelial cells","volume":"149","author":"Presta","year":"1991","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.bmc.2023.117368_b1200","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neuint.2017.02.015","article-title":"Neuroprotective effects of a novel peptide, FK18, under oxygen-glucose deprivation in SH-SY5Y cells and retinal ischemia in rats via the Akt pathway","volume":"108","author":"Xiong","year":"2017","journal-title":"Neurochem Int"},{"key":"10.1016\/j.bmc.2023.117368_b1205","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3892\/etm.2021.9880","article-title":"Protective effects of peptide FK18 against neuro-excitotoxicity in SH-SY5Y cells","volume":"21","author":"Xiong","year":"2021","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.bmc.2023.117368_b1210","first-page":"833","article-title":"Synthetic peptide F2A4-K-NS mimics fibroblast growth factor-2 in vitro and is angiogenic in vivo","volume":"17","author":"Lin","year":"2006","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.bmc.2023.117368_b1215","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1002\/jor.20215","article-title":"Augmentation of demineralized bone matrix (DBM) mineralization by a synthetic growth factor mimetic","volume":"24","author":"Lin","year":"2006","journal-title":"J Orthop Res"},{"key":"10.1016\/j.bmc.2023.117368_b1220","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/HP.0000000000000095","article-title":"A basic fibroblast growth factor analog for protection and mitigation against acute radiation syndromes","volume":"106","author":"Casey-Sawicki","year":"2014","journal-title":"Health Phys"},{"key":"10.1016\/j.bmc.2023.117368_b1225","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1021\/acsbiomaterials.7b00347","article-title":"Mimicking the bioactivity of fibroblast growth factor-2 using supramolecular nanoribbons","volume":"3","author":"Rubert P\u00e9rez","year":"2017","journal-title":"ACS Biomater Sci Eng"},{"key":"10.1016\/j.bmc.2023.117368_b1230","doi-asserted-by":"crossref","first-page":"15982","DOI":"10.1038\/ncomms15982","article-title":"Instructing cells with programmable peptide DNA hybrids","volume":"8","author":"Freeman","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmc.2023.117368_b1235","doi-asserted-by":"crossref","first-page":"10125","DOI":"10.7150\/thno.62525","article-title":"Peptide ligands targeting FGF receptors promote recovery from dorsal root crush injury via AKT\/mTOR signaling","volume":"11","author":"Zhao","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.bmc.2023.117368_b1240","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/70746","article-title":"Semirational design of a potent, artificial agonist of fibroblast growth factor receptors","volume":"17","author":"Ballinger","year":"1999","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.bmc.2023.117368_b1245","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1471-4159.2010.06718.x","article-title":"Peptides derived from specific interaction sites of the fibroblast growth factor 2 - FGF receptor complexes induce receptor activation and signaling","volume":"114","author":"Manf\u00e8","year":"2010","journal-title":"J Neurochem"},{"key":"10.1016\/j.bmc.2023.117368_b1250","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/dneu.20740","article-title":"Agonists of fibroblast growth factor receptor induce neurite outgrowth and survival of cerebellar granule neurons","volume":"69","author":"Li","year":"2009","journal-title":"Dev Neurobiol"},{"key":"10.1016\/j.bmc.2023.117368_b1255","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1471-4159.2007.05070.x","article-title":"Fibroblast growth factor-derived peptides: functional agonists of the fibroblast growth factor receptor","volume":"104","author":"Li","year":"2008","journal-title":"J Neurochem"},{"key":"10.1016\/j.bmc.2023.117368_b1260","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.3390\/ijms11062291","article-title":"Neuritogenic and neuroprotective properties of peptide agonists of the fibroblast growth factor receptor","volume":"11","author":"Li","year":"2010","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2023.117368_b1265","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neures.2010.05.002","article-title":"Effects of FGF receptor peptide agonists on animal behavior under normal and pathological conditions","volume":"68","author":"Rudenko","year":"2010","journal-title":"Neurosci Res"},{"key":"10.1016\/j.bmc.2023.117368_b1270","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1080\/15216549600201432","article-title":"Mitogenic activity of peptides related to the sequence of human Fibroblast Growth Factor-1","volume":"39","author":"Oyama","year":"1996","journal-title":"IUBMB Life"},{"key":"10.1016\/j.bmc.2023.117368_b1275","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1021\/jm020543e","article-title":"Introduction of a chemical constraint in a short peptide derived from human acidic fibroblast growth factor elicits mitogenic structural determinants","volume":"46","author":"Kiyota","year":"2003","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117368_b1280","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1110\/ps.035964.108","article-title":"Structural basis for the activation of FGFR by NCAM","volume":"17","author":"Kochoyan","year":"2008","journal-title":"Protein Sci"},{"key":"10.1016\/j.bmc.2023.117368_b1285","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1111\/j.1471-4159.2008.05544.x","article-title":"NCAM-derived peptides function as agonists for the fibroblast growth factor receptor","volume":"106","author":"Hansen","year":"2008","journal-title":"J Neurochem"},{"key":"10.1016\/j.bmc.2023.117368_b1290","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1471-4159.2005.03417.x","article-title":"A peptide from the first fibronectin domain of NCAM acts as an inverse agonist and stimulates FGF receptor activation, neurite outgrowth and survival","volume":"95","author":"Anderson","year":"2005","journal-title":"J Neurochem"},{"key":"10.1016\/j.bmc.2023.117368_b1295","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1007\/s11064-008-9680-2","article-title":"A peptide Motif from the second fibronectin module of the neural cell adhesion molecule, NCAM, NLIKQDDGGSPIRHY, is a binding site for the FGF receptor","volume":"33","author":"Jacobsen","year":"2008","journal-title":"Neurochem Res"},{"key":"10.1016\/j.bmc.2023.117368_b1300","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s11481-013-9501-5","article-title":"Fibroblast growth factor-2 signaling in neurogenesis and neurodegeneration","volume":"9","author":"Woodbury","year":"2014","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1016\/j.bmc.2023.117368_b1305","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1471-4159.2004.02779.x","article-title":"An NCAM-derived FGF-receptor agonist, the FGL-peptide, induces neurite outgrowth and neuronal survival in primary rat neurons","volume":"91","author":"Neiiendam","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.bmc.2023.117368_b1310","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2165\/00003088-200746040-00007","article-title":"Tolerability, safety and pharmacokinetics of the FGLL peptide, a novel mimetic of neural cell adhesion molecule, following intranasal administration in healthy volunteers","volume":"46","author":"Anand","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.bmc.2023.117368_b1315","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1111\/j.1460-9568.2005.04345.x","article-title":"A synthetic NCAM-derived peptide, FGL, protects hippocampal neurons from ischemic insult both in vitro and in vivo","volume":"22","author":"Skibo","year":"2005","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.bmc.2023.117368_b1320","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.neulet.2008.03.070","article-title":"The synthetic NCAM-derived peptide, FGL, modulates the transcriptional response to traumatic brain injury","volume":"437","author":"Pedersen","year":"2008","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.bmc.2023.117368_b1325","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.neuroscience.2006.04.059","article-title":"A neural cell adhesion molecule-derived fibroblast growth factor receptor agonist, the FGL-peptide, promotes early postnatal sensorimotor development and enhances social memory retention","volume":"141","author":"Secher","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.bmc.2023.117368_b1330","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1002\/jnr.22014","article-title":"Identification of neural cell adhesion molecule L1-derived neuritogenic ligands of the fibroblast growth factor receptor","volume":"87","author":"Kulahin","year":"2009","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.bmc.2023.117368_b1335","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1096\/fj.09-140509","article-title":"Neuroplastin-55 binds to and signals through the fibroblast growth factor receptor","volume":"24","author":"Owczarek","year":"2010","journal-title":"FASEB J"},{"key":"10.1016\/j.bmc.2023.117368_b1340","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/j.1471-4159.2011.07269.x","article-title":"Neuroplastin-65 and a mimetic peptide derived from its homophilic binding site modulate neuritogenesis and neuronal plasticity","volume":"117","author":"Owczarek","year":"2011","journal-title":"J Neurochem"},{"key":"10.1016\/j.bmc.2023.117368_b1345","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1002\/jnr.22380","article-title":"A peptide derived from a trans-homophilic binding site in neural cell adhesion molecule induces neurite outgrowth and neuronal survival","volume":"88","author":"K\u00f8hler","year":"2010","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.bmc.2023.117368_b1350","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.neulet.2011.07.010","article-title":"Impact of the NCAM derived mimetic peptide plannexin on the acute cellular consequences of a status epilepticus","volume":"501","author":"Zellinger","year":"2011","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.bmc.2023.117368_b1355","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1007\/s11064-018-2594-8","article-title":"NCAM mimetic peptides: potential therapeutic target for neurological disorders","volume":"43","author":"Chu","year":"2018","journal-title":"Neurochem Res"},{"key":"10.1016\/j.bmc.2023.117368_b1360","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.nbd.2012.07.016","article-title":"Neuroprotective and memory enhancing properties of a dual agonist of the FGF receptor and NCAM","volume":"48","author":"Enevoldsen","year":"2012","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.bmc.2023.117368_b1365","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/13697","article-title":"Identification of a neuritogenic ligand of the neural cell adhesion molecule using a combinatorial library of synthetic peptides","volume":"17","author":"R\u00f8nn","year":"1999","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.bmc.2023.117368_b1370","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1046\/j.1471-4159.2000.0750665.x","article-title":"Neurite outgrowth induced by a synthetic peptide ligand of neural cell adhesion molecule requires fibroblast growth factor receptor activation","volume":"75","author":"R\u00f8nn","year":"2000","journal-title":"J Neurochem"},{"key":"10.1016\/j.bmc.2023.117368_b1375","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.neulet.2009.01.080","article-title":"Insight into the structural mechanism of the bi-modal action of an NCAM mimetic, the C3 peptide","volume":"452","author":"Kiselyov","year":"2009","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.bmc.2023.117368_b1380","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1046\/j.1460-9568.2002.02242.x","article-title":"Characterization of a novel NCAM ligand with a stimulatory effect on neurite outgrowth identified by screening a combinatorial peptide library","volume":"16","author":"R\u00f8nn","year":"2002","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.bmc.2023.117368_b1385","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/jocd.12997","article-title":"An epidermis-permeable dipeptide is a potential cosmetic ingredient with partial agonist\/antagonist activity toward fibroblast growth factor receptors","volume":"19","author":"Yamada","year":"2020","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.bmc.2023.117368_b1390","volume":"US9206177B2","author":"Benazet","year":"2015","journal-title":"Substituted dimeric quinazoline-2,4-diones as FGF receptor agonists"},{"key":"10.1016\/j.bmc.2023.117368_b1395","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1039\/C6MD00121A","article-title":"Identification of novel peptoid agonists of fibroblast growth factor receptors using microarray-based screening","volume":"7","author":"Fu","year":"2016","journal-title":"MedChemComm"},{"key":"10.1016\/j.bmc.2023.117368_b1400","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1039\/C8CC08080A","article-title":"DNA aptamer assemblies as fibroblast growth factor mimics and their application in stem cell culture","volume":"55","author":"Ueki","year":"2019","journal-title":"Chem Commun"},{"key":"10.1016\/j.bmc.2023.117368_b1405","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102804","article-title":"A novel agonist with homobivalent single-domain antibodies that bind the FGF receptor 1 domain III functions as an FGF2 ligand","volume":"299","author":"Yonehara","year":"2023","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2023.117368_b1410","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/s41416-020-01157-0","article-title":"Fibroblast growth factor receptors in cancer: genetic alterations, diagnostics, therapeutic targets and mechanisms of resistance","volume":"124","author":"Krook","year":"2021","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bmc.2023.117368_b1415","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/2211-5463.12618","article-title":"Identification of a peptide antagonist of the FGF1-FGFR1 signaling axis by phage display selection","volume":"9","author":"Lipok","year":"2019","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.bmc.2023.117368_b1420","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1021\/acs.molpharmaceut.1c00946","article-title":"Drug conjugation via maleimide-thiol chemistry does not affect targeting properties of cysteine-containing anti-FGFR1 peptibodies","volume":"19","author":"Jendryczko","year":"2022","journal-title":"Mol Pharm"},{"key":"10.1016\/j.bmc.2023.117368_b1425","doi-asserted-by":"crossref","unstructured":"Ray J, Baird A, Gage FH. A 10-amino acid sequence of fibroblast growth factor 2 is sufficient for its mitogenic activity on neural progenitor\u2009cells. Proc Natl Acad Sci 1997;94:7047\u201352. 10.1073\/pnas.94.13.7047.","DOI":"10.1073\/pnas.94.13.7047"},{"key":"10.1016\/j.bmc.2023.117368_b1430","unstructured":"Benjamin H. et al. Peptide compounds useful for modulating FGF receptor activity. CA2270871A1; 2001."},{"key":"10.1016\/j.bmc.2023.117368_b1435","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1208\/s12248-015-9719-7","article-title":"Intranasal delivery of proteins and peptides in the treatment of neurodegenerative diseases","volume":"17","author":"Meredith","year":"2015","journal-title":"AAPS J"},{"key":"10.1016\/j.bmc.2023.117368_b1440","doi-asserted-by":"crossref","first-page":"286","DOI":"10.5853\/jos.2019.03048","article-title":"Optimizing stem cell therapy after ischemic brain injury","volume":"22","author":"Zhang","year":"2020","journal-title":"J Stroke"},{"key":"10.1016\/j.bmc.2023.117368_b1445","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jcrc.2020.05.004","article-title":"Informed consent procedures in patients with an acute inability to provide informed consent: policy and practice in the CENTER-TBI study","volume":"59","author":"van Wijk","year":"2020","journal-title":"J Crit Care"}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096808962300216X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096808962300216X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:25:08Z","timestamp":1760837108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096808962300216X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":289,"alternative-id":["S096808962300216X"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2023.117368","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Growth factors and their peptide mimetics for treatment of traumatic brain injury","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2023.117368","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"117368"}}